Diane M. McClintock
Analyst · KeyBanc Capital Markets
Thank you, Bob, and good morning, everyone. Please turn to Slide 4, which highlights our first quarter results. Sales reached $677 million, reflecting a 21% increase on a reported basis and a 12% increase organically. This performance was supported by favorable price and volume, including the benefit of growth in data center sales. The Americas region delivered strong organic growth of 16% and reported growth of 23%, exceeding our expectations. Acquisitions accounted for an additional $31 million in sales, contributing seven points to the Americas reported growth. In Europe, organic sales rose 1%, while reported sales increased 12%. Organic growth stemmed from favorable pricing, while reported sales also benefited from positive foreign exchange. In APMEA, organic sales grew 3%, with acquisitions adding 19% and favorable foreign exchange contributing 7% for a total reported sales growth of 29%. Adjusted EBITDA totaled $151 million, an increase of 27%, with an adjusted EBITDA margin of 22.3%, up 90 basis points year over year. Adjusted operating income of $136 million increased 28%, and adjusted operating margin improved 110 basis points to 20.1%. These improvements were primarily driven by favorable pricing, volume leverage, and productivity gains, more than offsetting inflationary pressure, tariffs, and acquisition dilution of 80 basis points. Segment margins were as follows: Americas increased 80 basis points to 24.2%, APMEA increased 120 basis points to 18.7%, while Europe decreased 20 basis points to 13.7%. Adjusted earnings per share equaled $3.04, representing a 28% year-over-year increase, with operational performance, acquisitions, tax, and foreign exchange gains outweighing higher net interest expense. The adjusted effective tax rate in the quarter was 24.2%, down 30 basis points compared to 2025, primarily due to a higher tax benefit from the vesting of stock compensation awards that occur in the first quarter of each year. Our free cash flow for the quarter was $7 million compared to $46 million in the first quarter of last year. The cash flow decrease was primarily due to the increase in accounts receivable due to higher sales volume, increases in and timing of our annual customer rebate payments, and an increase in inventory related to incremental tariffs and our strategic investment in inventory. We expect sequential improvement in our free cash flow and are on track to achieve our full-year goal of free cash flow conversion greater than or equal to 90% of net income, as previously communicated. We have a strong balance sheet and solid cash flow, giving us flexibility in executing our capital allocation strategy, including the announced 21% increase in our dividends that will begin in June. On Slide 5, we will review our outlook for the second quarter and full year 2026. We are reaffirming the full year 2026 outlook we presented in February, which reflects the market factors Bob discussed. It assumes the Middle East conflict is short term in nature, the current tariff structure remains in place for the remainder of the year, and there are no IEPA tariff refunds. For the full year 2026, we are maintaining both our consolidated and regional sales outlooks. Consolidated organic sales growth is expected to be between +2% and +6% and our reported sales growth is expected to be between +8% and +12%. We are also maintaining our full-year adjusted EBITDA and adjusted operating margin outlook. Next, a few items to consider for the second quarter. Reported sales are expected to increase by 10% to 14% with organic sales up 4% to 8%. We anticipate mid- to high-single-digit growth in the Americas, despite the tough compare to the second quarter last year, which included an estimated $20 million of pull-forward sales into the second quarter from the third quarter due to the timing of price increases. We expect a low-single-digit decline in Europe and low- to mid-single-digit growth in APMEA, with our expected data center sales offsetting the direct impact of the Middle East conflict. These estimates incorporate the negative impact from product rationalization under our 80/20 initiative of approximately $2 million in Europe and $6 million in the Americas. Incremental sales from acquisitions are projected at $25 million to $30 million for the Americas and around $5 million for APMEA. We also estimate a foreign exchange benefit of approximately $5 million. Second quarter EBITDA margin is expected to be between 22.3% and 22.9%. Operating margin is expected to be between 20.0% and 20.6%. Price and volume leverage in the Americas and APMEA are anticipated to be offset by acquisition dilution of 70 basis points. In addition, last year we had a nonrecurring price-cost benefit of approximately $6 million in the second quarter, in addition to the volume leverage on the estimated $20 million of sales pull-forward, that together are a 120 basis point headwind to margins in the second quarter. Additional key assumptions for the second quarter and full year are available in the appendix of the earnings presentation. With that, I will turn the call back over to Bob before moving to Q&A. Bob?